Private Wealth Management Group’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.8K Hold
500
– – ﹤0.01% 764
2026
Q2
$7.75K Hold
500
– – ﹤0.01% 658
2026
Q1
$3.22K Buy
+500
New +$4.71K ﹤0.01% 920

Other funds holding MTRI

Private Wealth Management Group's MTRI Position: Q3 2026 in Review

Private Wealth Management Group held its Mentari Therapeutics, Inc. Common Stock (MTRI) position steady in Q3 2026 at 500 shares worth $6.8K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

Private Wealth Management Group first reported a position in MTRI in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.75K in Q2 2026. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.

  • Private Wealth Management Group held 500 shares of Mentari Therapeutics, Inc. Common Stock worth $6.8K as of Q3 2026.
  • Private Wealth Management Group left its Mentari Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
  • Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #764 holding.
  • Private Wealth Management Group first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2026 and has held it in 3 quarters since.
  • Private Wealth Management Group's Mentari Therapeutics, Inc. Common Stock position peaked at $7.75K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.